CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...
Phase 3
Salisbury, North Carolina, United States and 17 other locations
The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...
Phase 3
Monroe, North Carolina, United States of America and 217 other locations
The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...
Phase 3
Monroe, North Carolina, United States of America and 159 other locations
This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI--...
Phase 2
Denver, North Carolina, United States of America and 54 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Charlotte, North Carolina, United States and 214 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Charlotte, North Carolina, United States and 114 other locations
This is a Phase 2/3, randomized, double-blind study to evaluate the safety and immunogenicity of different booster dose levels of the monovalent seve...
Phase 2, Phase 3
Gaffney, South Carolina, United States and 49 other locations
The study is divided into 2 parts: Part 1 and Part 2. The purpose of Part 1 of this study is to generate sufficient safety, reactogenicity, and immun...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 68 other locations
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr...
Phase 3
Charlotte, North Carolina, United States and 70 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...
Phase 3
Charlotte, North Carolina, United States and 246 other locations
Clinical trials
Research sites
Resources
Legal